Treosulfan

ATC L01AB02 · 7 markets · 21 records

Treosulfan 7 markets · 21 records Forms

GB 8 records · 3 strengths

5,000 mginjectionTrecondi 1g powder for solution for infusion+1__no_trade__ also in ES
1,000 mginjectionTrecondi 1g powder for solution for infusion+1__no_trade__ also in US
250 mgcapsuleNo trade name

CA 3 records · 2 strengths

5,000 mgpowderTRECONDYV+1treosulfan also in AU
1,000 mgpowderTRECONDYV also in AU

AU 3 records · 3 strengths

5,000 mgpowderTRECONDI treosulfan 1 g powder for injection for intravenous infusion vial also in CA unknown
1,000 mgpowderTRECONDI treosulfan 1 g powder for injection for intravenous infusion vial also in CA unknown

Records without a stated strength · 1 TRECONDI

US 2 records · 2 strengths

1,000 mginjectionGRAFAPEX also in GB
5,000 mg/5,000 mginjectionGRAFAPEX

SG 2 records · 2 strengths

5 g/vialinjectionTRECONDI POWDER FOR SOLUTION FOR INFUSION 5 G PER VIAL
1 g/vialinjectionTRECONDI POWDER FOR SOLUTION FOR INFUSION 5 G PER VIAL

ES 2 records · 1 strengths

5,000 mginjectionTRECONDI+1TREOSULFANO ZENTIVA also in GB

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 TRECONDI

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	ES	EU
5,000 mgRecorded as: 5 g injection	not recorded	No trade name Trecondi 1g powder for solution for infusion	not recorded	not recorded	not recorded	TRECONDI TREOSULFANO ZENTIVA	not recorded
1,000 mgRecorded as: 1 g injection	GRAFAPEX	No trade name Trecondi 1g powder for solution for infusion	not recorded	not recorded	not recorded	not recorded	not recorded
5,000 mgRecorded as: 5 g powder	not recorded	not recorded	TRECONDYV treosulfan	TRECONDI treosulfan 1 g powder for injection for intravenous infusion vial	not recorded	not recorded	not recorded
1,000 mgRecorded as: 1 g powder	not recorded	not recorded	TRECONDYV	TRECONDI treosulfan 1 g powder for injection for intravenous infusion vial	not recorded	not recorded	not recorded
250 mg capsule	not recorded	No trade name	not recorded	not recorded	not recorded	not recorded	not recorded
5,000 mg/5,000 mg injection	GRAFAPEX	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
5 g/vial injection	not recorded	not recorded	not recorded	not recorded	TRECONDI POWDER FOR SOLUTION FOR INFUSION 5 G PER VIAL	not recorded	not recorded
1 g/vial injection	not recorded	not recorded	not recorded	not recorded	TRECONDI POWDER FOR SOLUTION FOR INFUSION 5 G PER VIAL	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	TRECONDI	not recorded	not recorded	TRECONDI

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

2 more strength/form rows are recorded only in SG and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en SG que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 SG 有记录（未在本表显示）。另有 2 個規格/劑型僅在 SG 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.